HealthCap: Translating SFDR into a pragmatic fund framework
Type: Fund strategy
Timeline: 2023-2024
About HealthCap: HealthCap is a European venture capital firm investing globally in life sciences which has backed and built more than 127 companies, taken more than 45 companies public, and completed numerous trade sales.
Our work: Raison supported HealthCap’s Stockholm team define the sustainability ambition and SFDR classification for its new HealthCap IX fund, translating complex SFDR rules into a practical approach for promoting sustainability in early-stage venture companies across the full deal cycle.
Our contribution:
- Delivery of a clear, pragmatic and well-documented sustainability framework and supporting disclosures for HealthCap IX fund
- Provided recommendations on how to integrate sustainability into the investment process
“
Working with Raison on our ESG initiative has been a transformative experience for us. Their expertise and dedication significantly helped us to align our business with best practices and industry standards.”
Alex Valcu, Carl Kilander, Kristina Ekberg and Marile Schiess
HealthCap Stockholm